HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

mapatumumab

a fully human IgG1 agonistic mAb that exclusively targets tumor necrosis factor-related apoptosis-inducing ligand receptor (TRAIL-R1) which is overexpressed on the surface of many tumors
Also Known As:
HGS-1012; HGS-ETR1; HGS1012; TRAIL-R 1MAB; TRAIL-R1 MAB; TRM-1; TRM-1 HGS-ETR1
Networked: 42 relevant articles (7 outcomes, 13 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Humphreys, Robin: 6 articles (01/2013 - 08/2005)
2. Humphreys, R: 4 articles (04/2016 - 04/2005)
3. Fox, Norma Lynn: 4 articles (05/2014 - 04/2007)
4. Kakehi, Yoshiyuki: 3 articles (02/2015 - 05/2007)
5. Kim, Seog-Young: 3 articles (01/2013 - 05/2012)
6. Lee, Yong J: 3 articles (01/2013 - 05/2012)
7. Song, Xinxin: 3 articles (01/2013 - 05/2012)
8. El-Deiry, Wafik S: 2 articles (10/2019 - 01/2013)
9. Adam, Dieter: 2 articles (01/2019 - 07/2010)
10. Trauzold, Anna: 2 articles (01/2019 - 07/2010)

Related Diseases

1. Urinary Bladder Neoplasms (Bladder Cancer)
2. Neoplasms (Cancer)
3. Hyperthermia
4. Necrosis
5. Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)

Related Drugs and Biologics

1. Monoclonal Antibodies
2. Ligands
3. lexatumumab
4. TNF-Related Apoptosis-Inducing Ligand Receptors
5. Paclitaxel (Taxol)
6. Carboplatin (JM8)
7. Antibodies
8. Caspases
9. Rituximab (Mabthera)
10. drozitumab

Related Therapies and Procedures

1. Therapeutics
2. Drug Therapy (Chemotherapy)
3. Drug-Eluting Stents
4. Stents